Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

MMP and PKC inhibition reduce cutaneous contact hypersensitivity

Sep. 16, 2004

No Comments

VLA-1 receptor a target for psoriasis treatment

Sep. 16, 2004

No Comments

EO-1606 shows promise in multiple dermatological disease models

Sep. 15, 2004

No Comments

5-alpha Avocuta active in seborrhea

Sep. 15, 2004

No Comments

CollaGenex files for trademark Oracea for rosacea treatment Col-101

Sep. 15, 2004

No Comments

Schering AG names new derma company Intendis

Sep. 14, 2004

No Comments

Nucryst reports phase IIa results for NPI-32101 in atopic dermatitis

Sep. 10, 2004

No Comments

Characterization of the antiinflammatory effects of topical tacrolimus in atopic dermatitis

Sep. 7, 2004

No Comments

Clinical benefits of mepolizumab in eosinophilic skin disorders

Sep. 7, 2004

No Comments

NDA submission for Aczone

Sep. 3, 2004

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

MMP and PKC inhibition reduce cutaneous contact hypersensitivity

VLA-1 receptor a target for psoriasis treatment

EO-1606 shows promise in multiple dermatological disease models

5-alpha Avocuta active in seborrhea

CollaGenex files for trademark Oracea for rosacea treatment Col-101

Schering AG names new derma company Intendis

Nucryst reports phase IIa results for NPI-32101 in atopic dermatitis

Characterization of the antiinflammatory effects of topical tacrolimus in atopic dermatitis

Clinical benefits of mepolizumab in eosinophilic skin disorders

NDA submission for Aczone

Today's news in brief

Today's news in brief

Abbvie and Simcere enter a $1B T-cell engager deal

In monkeys, enhanced TB vaccine dissolves after inducing protection

New drugs with the same old resistance tricks?

Dermatologic RSS

Dermatologic
RSS